Litigation Details for ACTELION PHARMACEUTICALS LTD. v. NATCO PHARMA LIMITED (D.N.J. 2019)

ACTELION PHARMACEUTICALS LTD. v. NATCO PHARMA LIMITED (D.N.J. 2019)

Docket		Date Filed	2019-05-28
Court	District Court, D. New Jersey	Date Terminated	2019-11-25
Cause	28:1338 Patent Infringement	Assigned To	Brian R. Martinotti
Jury Demand	None	Referred To	Douglas Arpert
Parties	NATCO PHARMA LIMITED
Patents	8,309,126
Attorneys	KEITH J. MILLER
Firms	Robinson Miller LLC, Ironside Newark
Link to Docket	External link to docket

Details for ACTELION PHARMACEUTICALS LTD. v. NATCO PHARMA LIMITED (D.N.J. 2019)

Date Filed	Document No.	Description	Snippet	Link To Document
2019-05-28	1	Complaint	prior to the expiration of U.S. Patent No. 8,309,126 (the “’126 patent”). … This is a civil action for patent infringement arising under the patent laws of the United States, … THE PATENT-IN-SUIT 11. The ’126 patent, entitled “Dispersible Bosentan…copy of the ’126 patent is attached hereto as Exhibit A. 12. The ’126 patent claims dispersible…the ’126 patent is listed in the Orange Book in connection with NDA No. 209279 as a patent “with respect	External link to document
2019-11-25	16	Order of Dismissal	for infringement of United States Patent No. 8,309,126 (“the *126 patent”); WHEREAS, Actelion currently…expiration of the °126 Patent, including any patent term extensions and/or patent term adjustments and …of the *126 patent; WHEREAS, Natco agrees that Claims 4, 6, 7, 8, and 9 of the *126 patent are valid and…*126 patent would constitute acts of infringement of Claims 4, 6, 7, 8, and 9 of the *126 patent (““Asserted…CONSENT JUDGMENT AND ORDER WHEREAS, this action for patent infringement (“the Litigation”) was brought by	External link to document